Reducing the Immunogenicity of AAV through Engineering the Vector - George Church

(18:36)

AAV function

(40)

Basics of AAV Gene Therapy

(30:1econd)

AAV Vectors in the Eye - Shannon Boye

(26:32)

Dual-function AAV vector to prevent alpha-1 antitrypsin deficiency

(1:46)

Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene Therapy

(55:51)

Jayandharan G Rao: Adeno-associated virus biology, bioengineering and potential in gene therapy

(30:41)

Immunogenicity of AAV Vectors and Transgenes - Roland Herzog

(34:43)

Nanopore sequencing and functional screening of AAV genomes for optimal production and function

(15:)

How AAV Gene Transfer Works - Expert Audience

(2:51)

Analytical Ultracentrifugation for Characterization of AAV Gene Delivery Vectors

(47:14)

Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humans

(34:40)

AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method Development

(58:30)

1) Adeno Associated Virus (AAV) - An Introduction

(7:)

Ancestral AAV Capsid Reconstruction: Interrogating Viral Evolution to Inform Rational AAV Design

(34:57)

AAV Integration Summary and Implications

(6:1econd)

Webinar - A BRAVE Approach for Generating Noval AAV Vectors

(49:9)

AAV-mediated gene therapy approach: Ovid Therapeutics

(54:19)

AAV Engineering

(29:53)

Biopharma 101: Analysis of Adeno-associated Viral (AAV) Vectors (SCIEX Webinar)

(53:18)